FMISO

1

Review clinical trials related to FMISO. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

FMISO-based Adaptive Radiotherapy for Head and Neck Cancer

Hypoxia occurs in about 80% of head and neck tumors. Based on experimental and clinical data, hypoxia is a useful parameter for pretherapeutic stratification. These radioresistant regions can be detected with FMISO PET/CT. Moreover, hypoxic subvolumes of tumors can be evolving as target volumes for radiotherapy ("dose painting") in hypoxia imaging-based dose escalation.

Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital OlomoucUpdated: Apr 22, 2025Locations: 3
Eligibility criteria

Pathologically proven new diagnosis of oropharyngeal p16 negative, or laryngeal,... [+4]

Prior surgical treatment - any surgery of primary tumor or involved nodes or pri... [+8]